Trials / Conditions / Advanced HCC
Advanced HCC
5 registered clinical trials studyying Advanced HCC.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors NCT05906524 | Shanghai Kanda Biotechnology Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC NCT05831969 | Shenyang Tenth People's Hospital | Phase 2 |
| Completed | Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC NCT06818097 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Terminated | KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma NCT04601610 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Phase 1 / Phase 2 |
| Completed | Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma NCT00396682 | Hannover Medical School | Phase 3 |